Application 200914
- Type
- ANDA
- Sponsor
- MYLAN LABS LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CYTARABINE | CYTARABINE | INJECTABLE;INJECTION | 20MG/ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A200914-001 | CYTARABINE | CYTARABINE | 20MG/ML | INJECTABLE / INJECTION | 2011-12-13 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A200914-001 | CYTARABINE | 20MG/ML | INJECTABLE / INJECTION | 2011-12-13 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A200914-001 | CYTARABINE | 20MG/ML | INJECTABLE / INJECTION | 2011-12-13 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A200914-001 | CYTARABINE | 20MG/ML | INJECTABLE / INJECTION | 2011-12-13 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A200914-001 | CYTARABINE | 20MG/ML | INJECTABLE / INJECTION | 2011-12-13 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A200914-001 | CYTARABINE | 20MG/ML | INJECTABLE / INJECTION | 2011-12-13 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A200914-001 | AP | 1 | 74a2ff9319b5… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A200914-001 | AP | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A200914-001 | AP | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A200914-001 | AP | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A200914-001 | AP | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A200914-001 | AP | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A200914-001 | AP | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A200914-001 | AP | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cytarabine | CYTARABINE | Hospira, Inc. | e3a8c0e9-19ed-49b7-8464-11e8806f47fd | 2026-10-19 | Boxed warning, Warnings, Adverse reactions | Cytarabine CYTARABINE |
| Cytarabine | CYTARABINE | Hospira, Inc. | 277597b0-7d85-40a3-a34a-70c6a883fc6d | 2026-09-30 | Boxed warning, Warnings, Adverse reactions | Cytarabine CYTARABINE |
| CYTARABINE | CYTARABINE | Hospira, Inc. | 681b5dc4-4fcf-4fab-ad78-02cb9a4a5dd0 | 2026-09-30 | Boxed warning, Warnings, Adverse reactions | CYTARABINE CYTARABINE |
| Cytarabine | CYTARABINE | Hospira, Inc. | bc2fa221-ea56-48b8-8304-42cd81b8463b | 2026-09-30 | Boxed warning, Warnings, Adverse reactions | Cytarabine CYTARABINE |
| Cytarabine | CYTARABINE | Hospira, Inc. | 21e8e8e6-3f85-4fdd-8452-c9d14d2ef69a | 2026-09-30 | Boxed warning, Warnings, Adverse reactions | Cytarabine CYTARABINE |
| Cytarabine | CYTARABINE | Fresenius Kabi USA, LLC | c4fdc56e-efd7-4825-a518-ef430b2b3df0 | 2026-09-21 | Boxed warning, Warnings, Adverse reactions | Cytarabine CYTARABINE |
| Cytarabine | CYTARABINE | Meitheal Pharmaceuticals Inc. | 8105e590-fc7e-45b7-9604-c2d0d1be5eac | 2024-04-08 | Boxed warning, Warnings, Adverse reactions | Cytarabine CYTARABINE |
| cytarabine | CYTARABINE | Sagent Pharmaceuticals | 90f5c7ab-9f15-487d-ba69-ee4107434bcc | 2023-05-31 | Boxed warning, Warnings, Adverse reactions | cytarabine CYTARABINE |
| cytarabine | CYTARABINE | Sagent Pharmaceuticals | 9bc7f6c2-4b16-449b-b383-76106540206c | 2023-05-22 | Boxed warning, Warnings, Adverse reactions | cytarabine CYTARABINE |
| Cytarabine | CYTARABINE | Meitheal Pharmaceuticals Inc. | 8b366382-c8d1-4344-86b7-f65e92a8952b | 2022-08-29 | Boxed warning, Warnings, Adverse reactions | Cytarabine CYTARABINE |
| Cytarabine | CYTARABINE | Meitheal Pharmaceuticals Inc. | 1be2668b-d76f-4c65-aea9-86c5c40889a2 | 2022-07-06 | Boxed warning, Warnings, Adverse reactions | Cytarabine CYTARABINE |
| Cytarabine | CYTARABINE | Meitheal Pharmaceuticals Inc. | 446f6765-5375-6368-4755-4944574f5721 | 2022-01-14 | Boxed warning, Warnings, Adverse reactions | Cytarabine CYTARABINE |
| Cytarabine | CYTARABINE | Gland Pharma Limited | cb0db038-4a65-42c7-aa79-5c88309061df | 2020-07-14 | Boxed warning, Warnings, Adverse reactions | Cytarabine CYTARABINE |
| Cytarabine | CYTARABINE | Gland Pharma Limited | 7ab50348-ca78-46a5-aba6-c35b6b21fbfe | 2020-07-13 | Boxed warning, Warnings, Adverse reactions | Cytarabine CYTARABINE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.